Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IndoVac vs Covovax Immunogenicity & Safety in Indonesia
NCT05433285Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of IndoVac in coronavirus disease 2019 (COVID-19), sponsored by Bio Farma. Started Jun 2022; status: completed.
02
Drugs
IndoVac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05433285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433285.